-
1
-
-
0029051439
-
Hypoxia-inducible factor 1 is a basic-helix-loop-helix-PAS heterodimer regulated by cellular O2 tension
-
WANG GL, JIANG BH, RUE EA, SEMENZA GL. Hypoxia-inducible factor 1 is a basic-helix-loop-helix-PAS heterodimer regulated by cellular O2 tension. Proc Natl Acad Sci USA 1995; 92: 5510-5514. http://dx.doi.org/10.1073/pnas.92.12.5510
-
(1995)
Proc Natl Acad Sci USA
, vol.92
, pp. 5510-5514
-
-
Wang, G.L.1
Jiang, B.H.2
Rue, E.A.3
Semenza, G.L.4
-
2
-
-
0028816847
-
Purification and characterization of hypoxia-inducible factor 1
-
WANG GL, SEMENZA GL. Purification and characterization of hypoxia-inducible factor 1. J Biol Chem 1995;270: 1230-1237. http://dx.doi.org/10.1074/jbc.270.3.1230
-
(1995)
J Biol Chem
, vol.270
, pp. 1230-1237
-
-
Wang, G.L.1
Semenza, G.L.2
-
3
-
-
70349570410
-
HIF-1α modulates energy metabolism in cancer cells by inducing over-expression of specific glycolytic isoforms
-
MARÍN-HERNÁNDEZ A, GALLARDO-PÉREZ JC, RALPH SJ, RODRÍGUEZ-ENRÍQUEZ S, MORENO-SÁNCHEZ R. HIF-1α modulates energy metabolism in cancer cells by inducing over-expression of specific glycolytic isoforms. Mini Rev Med Chem 2009; 9: 1084-1101. http://dx.doi. org/10.2174/138955709788922610
-
(2009)
Mini Rev Med Chem
, vol.9
, pp. 1084-1101
-
-
Marín-Hernández, A.1
Gallardo-Pérez, J.C.2
Ralph, S.J.3
Rodríguez-Enríquez, S.4
Moreno-Sánchez, R.5
-
4
-
-
70350452792
-
Targeting the hypoxia-inducible factor (HIF) pathway in cancer
-
POON E, HARRIS AL, ASHCROFT M. Targeting the hypoxia-inducible factor (HIF) pathway in cancer. Expert Rev Mol Med 2009; 11: e26. http://dx.doi.org/10.1017/S1462399409001173
-
(2009)
Expert Rev Mol Med
, vol.11
-
-
Poon, E.1
Harris, A.L.2
Ashcroft, M.3
-
5
-
-
34547121206
-
Hypoxia in cancer: Significance and impact on clinical outcome
-
VAUPEL P, MAYER A. Hypoxia in cancer: significance and impact on clinical outcome. Cancer Metastasis Rev 2007; 26: 225-239. http://dx.doi.org/10.1007/s10555-007-9055-1
-
(2007)
Cancer Metastasis Rev
, vol.26
, pp. 225-239
-
-
Vaupel, P.1
Mayer, A.2
-
6
-
-
34547124062
-
Hypoxia: A key regulator of angiogenesis in cancer
-
LIAO D, JOHNSON RS. Hypoxia: a key regulator of angiogenesis in cancer. Cancer Metastasis Rev 2007;26: 281-290. http://dx.doi.org/10.1007/s10555-007-9066-y
-
(2007)
Cancer Metastasis Rev
, vol.26
, pp. 281-290
-
-
Liao, D.1
Johnson, R.S.2
-
7
-
-
10744231706
-
2ME2 inhibits tumor growth and angiogenesis by disrupting microtubules and dysregulating HIF
-
MABJEESH NJ, ESCUIN D, LAVALLEE TM, PRIBLUDA VS, SWARTZ GM et al. 2ME2 inhibits tumor growth and angiogenesis by disrupting microtubules and dysregulating HIF. Cancer Cell 2003; 3: 363-375. http://dx.doi.org/10.1016/S1535-6108(03)00077-1
-
(2003)
Cancer Cell
, vol.3
, pp. 363-375
-
-
Mabjeesh, N.J.1
Escuin, D.2
Lavallee, T.M.3
Pribluda, V.S.4
Swartz, G.M.5
-
8
-
-
79952706449
-
miR-449 inhibits cell proliferation and is down-regulated in gastric cancer
-
BOU KHEIR T, FUTOMA-KAZMIERCZAK E, JACOBSEN A, KROGH A, BARDRAM L et al. miR-449 inhibits cell proliferation and is down-regulated in gastric cancer. Mol Cancer 2011; 10: 29. http://dx.doi.org/10.1186/1476-4598-10-29
-
(2011)
Mol Cancer
, vol.10
, pp. 29
-
-
Bou Kheir, T.1
Futoma-Kazmierczak, E.2
Jacobsen, A.3
Krogh, A.4
Bardram, L.5
-
9
-
-
33747097563
-
Clinicopathologic significance of hypoxia-inducible factor 1alpha overexpression in gastric carcinomas
-
MIZOKAMI K, KAKEJI Y, ODA S, IRIE K, YONEMURA T et al. Clinicopathologic significance of hypoxia-inducible factor 1alpha overexpression in gastric carcinomas. J Surg Oncol 2006; 94: 149-154. http://dx.doi.org/10.1002/jso.20568
-
(2006)
J Surg Oncol
, vol.94
, pp. 149-154
-
-
Mizokami, K.1
Kakeji, Y.2
Oda, S.3
Irie, K.4
Yonemura, T.5
-
10
-
-
33749016506
-
Overexpression of hypoxia-inducible factor 1alpha and p53 is a marker for an unfavorable prognosis in gastric cancer
-
SUMIYOSHI Y, KAKEJI Y, EGASHIRA A, MIZOKAMI K, ORITA H et al. Overexpression of hypoxia-inducible factor 1alpha and p53 is a marker for an unfavorable prognosis in gastric cancer. Clin Cancer Res 2006; 12: 5112-5117. http://dx.doi.org/10.1158/1078-0432.CCR-05-2382
-
(2006)
Clin Cancer Res
, vol.12
, pp. 5112-5117
-
-
Sumiyoshi, Y.1
Kakeji, Y.2
Egashira, A.3
Mizokami, K.4
Orita, H.5
-
11
-
-
33645241816
-
Overexpression of hypoxia-inducible factor-1 alpha in gastric adenocarcinoma
-
URANO N, FUJIWARA Y, DOKI Y, TSUJIE M, YAMAMOTO H et al. Overexpression of hypoxia-inducible factor-1 alpha in gastric adenocarcinoma. Gastric Cancer 2006; 9: 44-49. http://dx.doi.org/10.1007/s10120-005-0356-1
-
(2006)
Gastric Cancer
, vol.9
, pp. 44-49
-
-
Urano, N.1
Fujiwara, Y.2
Doki, Y.3
Tsujie, M.4
Yamamoto, H.5
-
12
-
-
33846189403
-
Hypoxia-inducible factor-1alpha expression in the gastric carcinogenesis sequence and its prognostic role in gastric and gastro-oesophageal adenocarcinomas
-
GRIFFITHS EA, PRITCHARD SA, VALENTINE HR, WHITCHELO N, BISHOP PW et al. Hypoxia-inducible factor-1alpha expression in the gastric carcinogenesis sequence and its prognostic role in gastric and gastro-oesophageal adenocarcinomas. Br J Cancer 2007; 96: 95-103. http://dx.doi. org/10.1038/sj.bjc.6603524
-
(2007)
Br J Cancer
, vol.96
, pp. 95-103
-
-
Griffiths, E.A.1
Pritchard, S.A.2
Valentine, H.R.3
Whitchelo, N.4
Bishop, P.W.5
-
13
-
-
0037414180
-
YC-1: A potential anticancer drug targeting hypoxia-inducible factor 1
-
YEO EJ, CHUN YS, CHO YS, KIM J, LEE JC et al. YC-1: a potential anticancer drug targeting hypoxia-inducible factor 1. J Natl Cancer Inst 2003;95: 516-525. http://dx.doi. org/10.1093/jnci/95.7.516
-
(2003)
J Natl Cancer Inst
, vol.95
, pp. 516-525
-
-
Yeo, E.J.1
Chun, Y.S.2
Cho, Y.S.3
Kim, J.4
Lee, J.C.5
-
14
-
-
2942685341
-
Role of hypoxia-inducible factor 1alpha in gastric cancer cell growth, angiogenesis, and vessel maturation
-
STOELTZING O, MCCARTY MF, WEY JS, FAN F, LIU W et al. Role of hypoxia-inducible factor 1alpha in gastric cancer cell growth, angiogenesis, and vessel maturation. J Natl Cancer Inst 2004;96: 946-956. http://dx.doi.org/10.1093/jnci/djh168
-
(2004)
J Natl Cancer Inst
, vol.96
, pp. 946-956
-
-
Stoeltzing, O.1
McCarty, M.F.2
Wey, J.S.3
Fan, F.4
Liu, W.5
-
15
-
-
11144226693
-
Selective induction of apoptosis with proton pump inhibitor in gastric cancer cells
-
YEO M, KIM DK, KIM YB, OH TY, LEE JE et al. Selective induction of apoptosis with proton pump inhibitor in gastric cancer cells. Clin Cancer Res 2004; 10: 8687-8696. http://dx.doi.org/10.1158/1078-0432.CCR-04-1065
-
(2004)
Clin Cancer Res
, vol.10
, pp. 8687-8696
-
-
Yeo, M.1
Kim, D.K.2
Kim, Y.B.3
Oh, T.Y.4
Lee, J.E.5
-
16
-
-
0033870727
-
Hypoxia-inducible factor-1α is a positive factor in solid tumor growth
-
RYAN HE, POLONI M, MCNULTY W, ELSON D, GASSMANN M et al. Hypoxia-inducible factor-1α is a positive factor in solid tumor growth. Cancer Res 2000; 60: 4010-4015.
-
(2000)
Cancer Res
, vol.60
, pp. 4010-4015
-
-
Ryan, H.E.1
Poloni, M.2
McNulty, W.3
Elson, D.4
Gassmann, M.5
-
17
-
-
34047132303
-
Apigenin inhibits tumor angiogenesis through decreasing HIF-1α and VEGF expression
-
FANG J, ZHOU Q, LIU LZ, XIA C, HU X et al. Apigenin inhibits tumor angiogenesis through decreasing HIF-1α and VEGF expression. Carcinogenesis 2007; 28: 858-864. http://dx.doi.org/10.1093/carcin/bgl205
-
(2007)
Carcinogenesis
, vol.28
, pp. 858-864
-
-
Fang, J.1
Zhou, Q.2
Liu, L.Z.3
Xia, C.4
Hu, X.5
-
18
-
-
77950222705
-
Granulosa cell tumor with activated mTOR-HIF-1α-VEGF pathway
-
MIYAZAWA M, YASUDA M, FUJITA M, HIRABAYASHI K, HIRASAWA T et al. Granulosa cell tumor with activated mTOR-HIF-1α-VEGF pathway. J Obstet Gynaecol Res 2010; 36: 448-453. http://dx.doi.org/10.1111/j.1447-0756.2009.01127.x
-
(2010)
J Obstet Gynaecol Res
, vol.36
, pp. 448-453
-
-
Miyazawa, M.1
Yasuda, M.2
Fujita, M.3
Hirabayashi, K.4
Hirasawa, T.5
-
19
-
-
0032581277
-
Role of HIF-1α in hypoxia-mediated apoptosis, cell proliferation and tumour angiogenesis
-
CARMELIET P, DOR Y, HERBERT JM, FUKUMURA D, BRUSSELMANS K et al. Role of HIF-1α in hypoxia-mediated apoptosis, cell proliferation and tumour angiogenesis. Nature 1998; 394: 485-490. http://dx.doi.org/10.1038/28867
-
(1998)
Nature
, vol.394
, pp. 485-490
-
-
Carmeliet, P.1
Dor, Y.2
Herbert, J.M.3
Fukumura, D.4
Brusselmans, K.5
-
20
-
-
0032568150
-
Stabilization of wild-type p53 by hypoxia-inducible factor 1α
-
AN WG, KANEKAL M, SIMON MC, MALTEPE E, BLAGOSKLONNY MV et al. Stabilization of wild-type p53 by hypoxia-inducible factor 1α. Nature 1998; 392: 405-408. http://dx.doi.org/10.1038/32925
-
(1998)
Nature
, vol.392
, pp. 405-408
-
-
An, W.G.1
Kanekal, M.2
Simon, M.C.3
Maltepe, E.4
Blagosklonny, M.V.5
-
21
-
-
69249211007
-
Effects and mechanisms of proton pump inhibitors as a novel chemosensitizer on human gastric adenocarcinoma (SGC7901) cells
-
CHEN M, ZOU X, LUO H, CAO J, ZHANG X et al. Effects and mechanisms of proton pump inhibitors as a novel chemosensitizer on human gastric adenocarcinoma (SGC7901) cells. Cell Biol Int 2009; 33: 1008-1019. http://dx.doi.org/10.1016/j.cellbi.2009.05.004
-
(2009)
Cell Biol Int
, vol.33
, pp. 1008-1019
-
-
Chen, M.1
Zou, X.2
Luo, H.3
Cao, J.4
Zhang, X.5
-
22
-
-
77958033377
-
Treatment with a proton pump inhibitor improves glycaemic control in Psammomys obesus, a model of type 2 diabetes
-
BÖDVARSDÓTTIR TB, HOVE KD, GOTFREDSEN CF, PRIDAL L, VAAG A et al. Treatment with a proton pump inhibitor improves glycaemic control in Psammomys obesus, a model of type 2 diabetes. Diabetologia 2010; 53: 2220-2223. http://dx.doi.org/10.1007/s00125-010-1825-6
-
(2010)
Diabetologia
, vol.53
, pp. 2220-2223
-
-
Bödvarsdóttir, T.B.1
Hove, K.D.2
Gotfredsen, C.F.3
Pridal, L.4
Vaag, A.5
-
23
-
-
70349308397
-
Lansoprazole, a proton pump inhibitor, mediates anti-inflammatory effect in gastric mucosal cells through the induction of heme oxygenase-1 via activation of NF-E2-related factor 2 and oxidation of kelch-like ECH-associating protein 1
-
TAKAGI T, NAITO Y, OKADA H, ISHII T, MIZUSHIMA K et al. Lansoprazole, a proton pump inhibitor, mediates anti-inflammatory effect in gastric mucosal cells through the induction of heme oxygenase-1 via activation of NF-E2-related factor 2 and oxidation of kelch-like ECH-associating protein 1. J Pharmacol Exp Ther 2009; 331: 255-264. http://dx.doi. org/10.1124/jpet.109.152702
-
(2009)
J Pharmacol Exp Ther
, vol.331
, pp. 255-264
-
-
Takagi, T.1
Naito, Y.2
Okada, H.3
Ishii, T.4
Mizushima, K.5
-
24
-
-
34347354298
-
Negative inotropy of the gastric proton pump inhibitor pantoprazole in myocardium from humans and rabbits: Evaluation of mechanisms
-
SCHILLINGER W, TEUCHER N, SOSSALLA S, KETTLEWELL S, WERNER C et al. Negative inotropy of the gastric proton pump inhibitor pantoprazole in myocardium from humans and rabbits: evaluation of mechanisms. Circulation 2007; 116: 57-66. http://dx.doi.org/10.1161/CIRCULATIONAHA.106.666008
-
(2007)
Circulation
, vol.116
, pp. 57-66
-
-
Schillinger, W.1
Teucher, N.2
Sossalla, S.3
Kettlewell, S.4
Werner, C.5
-
25
-
-
2942724235
-
mTOR inhibition reverses Akt-dependent prostate intraepithelial neoplasia through regulation of apoptotic and HIF-1-dependent pathways
-
MAJUMDER PK, FEBBO PG, BIKOFF R, BERGER R, XUE Q et al. mTOR inhibition reverses Akt-dependent prostate intraepithelial neoplasia through regulation of apoptotic and HIF-1-dependent pathways. Nat Med 2004; 10: 594-601. http://dx.doi.org/10.1038/nm1052
-
(2004)
Nat Med
, vol.10
, pp. 594-601
-
-
Majumder, P.K.1
Febbo, P.G.2
Bikoff, R.3
Berger, R.4
Xue, Q.5
-
26
-
-
33744829237
-
CCI-779 inhibits rhabdomyosarcoma xenograft growth by an antiangiogenic mechanism linked to the targeting of mTOR/Hif-1α/VEGF Signaling
-
WAN X, SHEN N, MENDOZA A, KHANNA C HELMAN LJ. CCI-779 inhibits rhabdomyosarcoma xenograft growth by an antiangiogenic mechanism linked to the targeting of mTOR/Hif-1α/VEGF Signaling. Neoplasia 2006; 8: 394-401. http://dx.doi.org/10.1593/neo.05820
-
(2006)
Neoplasia
, vol.8
, pp. 394-401
-
-
Wan, X.1
Shen, N.2
Mendoza, A.3
Khanna Helman, L.J.C.4
-
27
-
-
33748742635
-
Cross-talk between epidermal growth factor receptor and hypoxia-inducible factor-1α signal pathways increases resistance to apoptosis by up-regulating survivin gene expression
-
PENG XH, KARNA P, CAO Z, JIANG BH, ZHOU M et al. Cross-talk between epidermal growth factor receptor and hypoxia-inducible factor-1α signal pathways increases resistance to apoptosis by up-regulating survivin gene expression. J Biol Chem 2006; 281: 25903-25914. http://dx.doi.org/10.1074/jbc. M603414200
-
(2006)
J Biol Chem
, vol.281
, pp. 25903-25914
-
-
Peng, X.H.1
Karna, P.2
Cao, Z.3
Jiang, B.H.4
Zhou, M.5
-
28
-
-
0037111665
-
BCR/ABL induces expression of vascular endothelial growth factor and its transcriptional activator, hypoxia inducible factor-1α, through a pathway involving phosphoinositide 3-kinase and the mammalian target of rapamycin
-
MAYERHOFER M, VALENT P, SPERR WR, GRIFFIN JD SILLABER C. BCR/ABL induces expression of vascular endothelial growth factor and its transcriptional activator, hypoxia inducible factor-1α, through a pathway involving phosphoinositide 3-kinase and the mammalian target of rapamycin. Blood 2002; 100: 3767-3775. http://dx.doi. org/10.1182/blood-2002-01-0109
-
(2002)
Blood
, vol.100
, pp. 3767-3775
-
-
Mayerhofer, M.1
Valent, P.2
Sperr, W.R.3
Griffin Jd Sillaber, C.4
-
29
-
-
0037862921
-
The effect of trastuzumab/docatexel combination on breast cancer angiogenesis: Dichotomus effect predictable by the HIF1α/VEGF pre-treatment status?
-
KOUKOURAKIS MI, SIMOPOULOS C, POLYCHRONIDIS A, PERENTE S, BOTAITIS S et al. The effect of trastuzumab/docatexel combination on breast cancer angiogenesis: dichotomus effect predictable by the HIF1α/VEGF pre-treatment status? Anticancer Res 2003; 23: 1673-1680.
-
(2003)
Anticancer Res
, vol.23
, pp. 1673-1680
-
-
Koukourakis, M.I.1
Simopoulos, C.2
Polychronidis, A.3
Perente, S.4
Botaitis, S.5
-
30
-
-
0036359548
-
Hypoxia-a key regulatory factor in tumour growth
-
HARRIS AL. Hypoxia-a key regulatory factor in tumour growth. Nat Rev Cancer 2002; 2: 38-47. http://dx.doi.org/10.1038/nrc704
-
(2002)
Nat Rev Cancer
, vol.2
, pp. 38-47
-
-
Harris, A.L.1
-
31
-
-
0033587146
-
The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis
-
MAXWELL PH, WIESENER MS, CHANG GW, CLIFFORD SC, VAUX EC et al. The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis. Nature 1999; 399: 271-275. http://dx.doi. org/10.1038/2045
-
(1999)
Nature
, vol.399
, pp. 271-275
-
-
Maxwell, P.H.1
Wiesener, M.S.2
Chang, G.W.3
Clifford, S.C.4
Vaux, E.C.5
-
32
-
-
0035917808
-
Targeting of HIF-α to the von Hippel-Lindau ubiquitylation complex by O2-regulated prolyl hydroxylation
-
JAAKKOLA P, MOLE DR, TIAN YM, WILSON MI, GIELBERT J et al. Targeting of HIF-α to the von Hippel-Lindau ubiquitylation complex by O2-regulated prolyl hydroxylation. Science 2001; 292: 468-472. http://dx.doi.org/10.1126/science.1059796
-
(2001)
Science
, vol.292
, pp. 468-472
-
-
Jaakkola, P.1
Mole, D.R.2
Tian, Y.M.3
Wilson, M.I.4
Gielbert, J.5
-
33
-
-
3242725198
-
HIF activation by pH-dependent nucleolar sequestration of VHL
-
MEKHAIL K, GUNARATNAM L, BONICALZI ME LEE S. HIF activation by pH-dependent nucleolar sequestration of VHL. Nat. Cell Biol. 2004; 6: 642-647. http://dx.doi. org/10.1038/ncb1144
-
(2004)
Nat Cell Biol
, vol.6
, pp. 642-647
-
-
Mekhail, K.1
Gunaratnam, L.2
Bonicalzi Me Lee, S.3
-
34
-
-
9744260934
-
Effect of proton pump inhibitor pretreatment on resistance of solid tumors to cytotoxic drugs
-
LUCIANI F, SPADA M, MILITO AD, MOLINARI A, RIVOLTINI L et al. Effect of proton pump inhibitor pretreatment on resistance of solid tumors to cytotoxic drugs. J Natl Cancer Inst 2004; 96: 1702-1713. http://dx.doi.org/10.1093/jnci/djh305
-
(2004)
J Natl Cancer Inst
, vol.96
, pp. 1702-1713
-
-
Luciani, F.1
Spada, M.2
Milito, A.D.3
Molinari, A.4
Rivoltini, L.5
-
35
-
-
67349244880
-
A novel benzimidazole analogue inhibits the hypoxiainducible factor (HIF)-1 pathway
-
WON MS, IM N, PARK S, BOOVANAHALLI SK, JIN Y et al. A novel benzimidazole analogue inhibits the hypoxiainducible factor (HIF)-1 pathway. Biochem Biophys Res Commun 2009; 385: 16-21. http://dx.doi.org/10.1016/j.bbrc.2009.05.022
-
(2009)
Biochem Biophys Res Commun
, vol.385
, pp. 16-21
-
-
Won, M.S.1
Im, N.2
Park, S.3
Boovanahalli, S.K.4
Jin, Y.5
-
36
-
-
0344552888
-
RNA interference for HIF-1α inhibits its downstream signalling and affects cellular proliferation
-
HÄNZE J, EUL BG, SAVAI R, KRICK S, GOYAL P et al. RNA interference for HIF-1α inhibits its downstream signalling and affects cellular proliferation. Biochem Biophys Res Commun 2003; 312: 571-577. http://dx.doi.org/10.1016/j.bbrc.2003.10.153
-
(2003)
Biochem Biophys Res Commun
, vol.312
, pp. 571-577
-
-
Hänze, J.1
Eul, B.G.2
Savai, R.3
Krick, S.4
Goyal, P.5
-
37
-
-
34547493149
-
Hydroxylation of hypoxia-inducible transcription factors and chemical compounds targeting the HIF-α hydroxylases
-
BRUEGGE K, JELKMANN W METZEN E. Hydroxylation of hypoxia-inducible transcription factors and chemical compounds targeting the HIF-α hydroxylases. Curr Med Chem 2007; 14: 1853-1862.
-
(2007)
Curr Med Chem
, vol.14
, pp. 1853-1862
-
-
Bruegge, K.1
Jelkmann Metzen, E.W.2
|